ALPHARETTA, Ga., Sept. 26, 2019 /PRNewswire/ -- Avanos
Medical, Inc. (NYSE: AVNS) today announced publication acceptance
from a large retrospective study demonstrating long-term clinical
effectiveness of COOLIEF* Cooled Radiofrequency (RF) for patients
suffering from chronic osteoarthritic knee pain in a diverse
patient population.
The study, published in Pain Physician, was a
retrospective assessment of the long-term effectiveness of cooled
radiofrequency ablation (CRFA) using COOLIEF* Cooled RF in
183 patients following standard of care at a single-site pain
practice. Results showed that after CRFA, 65 percent of patients
reported more than 50 percent pain relief lasting a mean
of 12.5 months (0-35 months; median 12 months). Patients
showed an average reduction in Visual Analog Scale (VAS) pain
scores from 8.5 cm to 4.2 cm after CRFA and 26 patients (14
percent) reported having no pain at all following the
procedure.
The assessment was conducted by Leonardo Kapural, M.D., Ph.D.,
pain physician at the Carolinas Pain Institute and Center for
Clinical Research, and professor of Anesthesiology at Wake Forest University School of Medicine. Dr.
Kapural specializes in innovative pain treatments and has relied on
COOLIEF* Cooled RF to treat and manage chronic pain conditions in
patients for the last 10 years. "The evidence in the study
reinforces previous studies demonstrating that COOLIEF* Cooled RF
consistently offers long-term pain relief for chronic knee pain
patients in a real-world setting," Dr. Kapural said. "Collectively,
the data further suggests that COOLIEF* Cooled RF should be
considered the standard of care for those suffering from chronic OA
knee pain."
"Approximately 100 million U.S. adults—more than the number
affected by heart disease, diabetes, and cancer combined—suffer
from chronic pain conditions," said Justin
T. Martin, global marketing director, interventional pain
management at Avanos. "While there continues to be positive
momentum in the emergence of new non-opioid, non-surgical products
to treat chronic conditions such as OA knee pain, this data
reaffirms COOLIEF* Cooled RF as an effective solution as it
decreases chronic pain, improves quality of life and delivers a
high degree of treatment satisfaction in patients with chronic knee
pain."
For more information about COOLIEF* Cooled Radiofrequency for
the management of chronic pain, visit avanospainmanagement.com.
About Avanos Medical, Inc.
Avanos Medical, Inc. (NYSE: AVNS) is a medical technology company
focused on delivering clinically superior breakthrough medical
device solutions to improve patients' quality of
life. Headquartered in Alpharetta,
Ga., Avanos is committed to addressing some of today's most
important healthcare needs, such as reducing the use of opioids
while helping patients move from surgery to recovery. Avanos
develops, manufactures and markets its recognized brands in more
than 90 countries.
For more information, visit avanos.com.
View original content to download
multimedia:http://www.prnewswire.com/news-releases/new-data-supports-coolief-cooled-radiofrequency-to-be-effective-in-relieving-chronic-knee-pain-300926533.html
SOURCE Avanos Medical, Inc.